ghk-cu wound healing clinical trial randomized Copper Peptides: 50 Years of Research, Explained ghk-cu clinical trial skin anti-aging

The wound closure was quantified by measuring the relative density of the wound in the scratched area compared to the confluent area and expressed as relative wound density (%)

The most extensively studied is GHK-Cu (glycyl-L-histidyl-L-lysine copper), a tripeptide first isolated in 1973 by American biochemist Dr Loren Pickart

It is a skin conditioning agent that creates a thin, breathable film to reduce water loss during cleansing

The characteristic dark blue color of reconstituted GHK-Cu provides a visual quality check

Topical Aesthetic Uses GHK-Cu serums and creams are often integrated into: Post-microneedling protocols Post-laser healing Anti-aging skincare regimens Sensitive skin barrier support Acne scar recovery plans Adjunctive Regenerative Support Used alongside modalities such as: PRP Exosomes Energy-based devices Chemical resurfacing GHK-Cu may help enhance healing and reduce inflammation, although more comparative research is needed